559
Views
22
CrossRef citations to date
0
Altmetric
Review

Obstructive sleep apnoea and comorbidity – an overview of the association and impact of continuous positive airway pressure therapy

Pages 251-261 | Received 15 Nov 2018, Accepted 24 Jan 2019, Published online: 11 Feb 2019

References

  • Levy P, Kohler M, McNicholas WT, et al. Obstructive sleep apnoea syndrome. Nat Rev Dis Primers. 2015;1:1–20.
  • Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328(17):1230–1235.
  • Heinzer R, Vat S, Marques-Vidal P, et al. Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. Lancet Respir Med. 2015;3(4):310–318.
  • Mokhlesi B, Ham SA, Gozal D. The effect of sex and age on the comorbidity burden of OSA: an observational analysis from a large nationwide US health claims database. Eur Respir J. 2016;47(4):1162–1169.
  • Molnar MZ, Mucsi I, Novak M, et al. Association of incident obstructive sleep apnea with outcomes in a large cohort of US Veterans. Thorax. 2015;70(9):888–895.
  • McEvoy RD, Antic NA, Heeley E, et al. CPAP for prevention of cardiovascular events in obstructive sleep apnea. N Engl J Med. 2016;375(10):919–931.
  • Jennum P, Tønnesen P, Ibsen R, et al. Obstructive sleep apnea: effect of comorbidities and positive airway pressure on all-cause mortality. Sleep Med. 2017;36:62–66.
  • Castro-Grattoni AL, Alvarez-Buvé R, Torres M, et al. Intermittent hypoxia-induced cardiovascular remodeling is reversed by normoxia in a mouse model of sleep apnea. Chest. 2016;149(6):1400–1408.
  • Lavie L. Oxidative stress in obstructive sleep apnea and intermittent hypoxia–revisited–the bad ugly and good: implications to the heart and brain. Sleep Med Rev. 2015;20:27–45.
  • Garvey JF, Taylor CT, McNicholas WT. Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation. Eur Respir J. 2009;33(5):1195–1205.
  • Vgontzas AN, Gaines J, Ryan S, et al. CrossTalk proposal: metabolic syndrome causes sleep apnoea. J Physiol. 2016;594(17):4687–4690.
  • Deegan PC, McNicholas WT. Pathophysiology of obstructive sleep apnoea. Eur Respir J. 1995;8(7):1161–1178.
  • Crinion SJ, Ryan S, McNicholas WT. Obstructive sleep apnoea as a cause of nocturnal nondipping blood pressure: recent evidence regarding clinical importance and underlying mechanisms. Eur Respir J. 2017;49(1):1601818.
  • Ryan S, Taylor CT, McNicholas WT. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation. 2005;112:2660–2667.
  • Hoyos CM, Melehan KL, Liu PY, et al. Does obstructive sleep apnea cause endothelial dysfunction? A critical review of the literature. Sleep Med Rev. 2015;20:15–26.
  • Calvin AD, McKenna M, Borges ÁH, et al. Experimental sleep restriction causes endothelial dysfunction in healthy humans. J Am Heart Assoc. 2014;3(6):e001143.
  • Hoyos CM, Drager LF, Patel SR. OSA and cardiometabolic risk: what’s the bottom line? Respirology. 2017;22(3):420–429.
  • Heinzer R, Marti-Soler H, Haba-Rubio J. Prevalence of sleep apnoea syndrome in the middle to old age general population. Lancet Respir Med. 2016;4(2):e5–e6.
  • Murphy AM, Thomas A, Crinion SJ, et al. Intermittent hypoxia in obstructive sleep apnoea mediates insulin resistance through adipose tissue inflammation. Eur Respir J. 2017;49(4):1601731.
  • White LH, Bradley TD. Role of nocturnal rostral fluid shift in the pathogenesis of obstructive and central sleep apnoea. J Physiol. 2013;591(Pt 5):1179–1193.
  • Sharma S, Culebras A. Sleep apnoea and stroke. Stroke Vasc Neurol. 2016;1(4):185–191.
  • Mims KN, Kirsch D. Sleep and stroke. Sleep Med Clin. 2016;11(1):39–51.
  • Huang T, Lin BM, Stampfer MJ, et al. A population-based study of the bidirectional association between obstructive sleep apnea and type 2 diabetes in three prospective U.S. cohorts. Diabetes Care. 2018;41(10):2111–2119.
  • McNicholas WT, Bonsignore MR, Bonsignore MR. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J. 2007;29(1):156–178.
  • Dong J-Y, Zhang Y-H, Qin L-Q. Obstructive sleep apnea and cardiovascular risk: meta-analysis of prospective cohort studies. Atherosclerosis. 2013;229(2):489–495.
  • Jenner R, Fatureto-Borges F, Costa-Hong V, et al. Association of obstructive sleep apnea with arterial stiffness and nondipping blood pressure in patients with hypertension. J Clin Hypertens. 2017;19(9):910–918.
  • Parati G, Lombardi C, Hedner J, et al. Recommendations for the management of patients with obstructive sleep apnoea and hypertension. Eur Respir J. 2013;41(3):523–538.
  • Ryan S, Ward S, Heneghan C, et al. Predictors of decreased spontaneous baroreflex sensitivity in obstructive sleep apnea syndrome. Chest. 2007;131(4):1100–1107.
  • Zalucky AA, Nicholl DDM, Hanly PJ, et al. Nocturnal hypoxemia severity and renin–angiotensin system activity in obstructive sleep apnea. Am J Respir Crit Care Med. 2015;192(7):873–880.
  • Linz D, McEvoy RD, Cowie MR, et al. Associations of obstructive sleep apnea with atrial fibrillation and continuous positive airway pressure treatment: A review. JAMA Cardiol. 2018;3(6):532–540.
  • Heneghan C, Chua C-P, Garvey JF, et al. A portable automated assessment tool for sleep apnea using a combined holter-oximeter. Sleep. 2008;31(10):1432–1439.
  • Grasso I, Haigney M, Mortara D, et al. Detection of sleep-disordered breathing with ambulatory Holter monitoring. Sleep Breathing. 2018;22:1021–1028.
  • Iwasaki Y-K, Kato T, Xiong F, et al. Atrial fibrillation promotion with long-term repetitive obstructive sleep apnea in a rat model. J Am Coll Cardiol. 2014;64(19):2013–2023.
  • May AM, Van Wagoner DR, Mehra R. OSA and cardiac arrhythmogenesis: mechanistic insights. Chest. 2017;151(1):225–241.
  • Castro-Grattoni AL, Wedzicha JA, Iversen M, et al. Blood pressure response to CPAP treatment in subjects with obstructive sleep apnoea: the predictive value of 24-h ambulatory blood pressure monitoring. Eur Respir J. 2017;50(4).
  • Tung P, Levitzky YS, Wang R, et al. Obstructive and central sleep apnea and the risk of incident atrial fibrillation in a community cohort of men and women. J Am Heart Assoc. 2017;6(7):e004500.
  • Patel NJ, Wells QS, Huang S, et al. Relation of obstructive sleep apnea and a common variant at chromosome 4q25 to atrial fibrillation. Am J Cardiol. 2017;119(9):1387–1391.
  • Kent BD, Garvey JF, Ryan S, et al. Severity of obstructive sleep apnoea predicts coronary artery plaque burden: a coronary computed tomographic angiography study. Eur Respir J. 2013;42(5):1263–1270.
  • Gottlieb DJ, Yenokyan G, Newman AB, et al. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure. Circulation. 2010;122(4):352–360.
  • Javaheri S, Sharma RK, Wang R, et al. Association between obstructive sleep apnea and left ventricular structure by age and gender: the multi-ethnic study of atherosclerosis. Sleep. 2016;39(3):523–529.
  • Xie J, Sert Kuniyoshi FH, Covassin N, et al. Nocturnal hypoxemia due to obstructive sleep apnea is an independent predictor of poor prognosis after myocardial infarction. J Am Heart Assoc. 2016;5(8):e003162.
  • Leão S, Conde B, Fontes P, et al. Effect of obstructive sleep apnea in acute coronary syndrome. Am J Cardiol. 2016;117(7):1084–1087.
  • Roca GQ, Redline S, Claggett B, et al. Sex-specific association of sleep apnea severity with subclinical myocardial injury, ventricular hypertrophy, and heart failure risk in a community dwelling cohort: the atherosclerosis risk in communities-sleep heart health study. Circulation. 2015;132(14):1329–1337.
  • Campos-Rodriguez F, Martinez-Garcia MA, Reyes-Nuñez N, et al. Role of sleep apnea and continuous positive airway pressure therapy in the incidence of stroke or coronary heart disease in women. Am J Respir Crit Care Med. 2014;189(12):1544–1550.
  • Marin JM, Carrizo S, Vicente E, et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005;365(9464):1046–1053.
  • Doherty LS, Kiely JL, Swan V, et al. Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome*. Chest. 2005;127(6):2076–2084.
  • Martínez-García M-A, Campos-Rodríguez F, Catalán-Serra P, et al. Cardiovascular mortality in obstructive sleep apnea in the elderly: role of long-term continuous positive airway pressure treatment. Am J Respir Crit Care Med. 2012;186(9):909–916.
  • Qureshi WT, Nasir UB, Alqalyoobi S, et al. Meta-analysis of continuous positive airway pressure as a therapy of atrial fibrillation in obstructive sleep apnea. Am J Cardiol. 2015;116(11):1767–1773.
  • Becker HF, Jerrentrup A, Ploch T, et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation. 2003;107(1):68–73.
  • Pepperell JCT, Ramdassingh-Dow S, Crosthwaite N, et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet. 2002;359(9302):204–210.
  • Martínez-García M, Capote F, Campos-Rodríguez F, et al. Effect of cpap on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the hiparco randomized clinical trial. JAMA. 2013;310(22):2407–2415.
  • Sapiña-Beltrán E, Santamaria-Martos F, Benítez I, et al. Normotensive patients with obstructive sleep apnoea: changes in 24-h ambulatory blood pressure monitoring with continuous positive airway pressure treatment. J Hypertens. 2018. (Publish Ahead of Print, SEP 2018).
  • Korcarz CE, Benca R, Barnet JH, et al. Treatment of obstructive sleep apnea in young and middle‐aged adults: effects of positive airway pressure and compliance on arterial stiffness, endothelial function, and cardiac hemodynamics. J Am Heart Assoc. 2016;5(4):e002930.
  • Peker Y, Glantz H, Eulenburg C, et al. Effect of positive airway pressure on cardiovascular outcomes in coronary artery disease patients with nonsleepy obstructive sleep apnea. the riccadsa randomized controlled trial. Am J Respir Crit Care Med. 2016;194(5):613–620.
  • McNicholas WT. Continuous positive airway pressure therapy and cardiovascular outcomes in obstructive sleep apnoea syndrome: where are we now? J Thorac Dis. 2016;8(12):E1644–E1646.
  • Abuzaid AS, Ashry HS, Elbawadi A, et al. Meta-analysis of cardiovascular outcomes with continuous positive airway pressure therapy in patients with obstructive sleep apnea. Am J Cardiol. 2017;120(4):693–699.
  • Kent BD, McNicholas WT, Ryan S. Insulin resistance, glucose intolerance and diabetes mellitus in obstructive sleep apnoea. J Thorac Dis. 2015;7(8):1343–1357.
  • Reutrakul S, Mokhlesi B. Obstructive sleep apnea and diabetes: a state of the art review. Chest. 2017;152(5):1070–1086.
  • Reutrakul S, Thakkinstian A, Anothaisintawee T, et al. Sleep characteristics in type 1 diabetes and associations with glycemic control: systematic review and meta-analysis. Sleep Med. 2016;23:26–45.
  • Reichmuth KJ, Austin D, Skatrud JB, et al. Association of sleep apnea and type II diabetes. Am J Respir Crit Care Med. 2005;172(12):1590–1595.
  • Kent BD, Grote L, Ryan S, et al. Diabetes mellitus prevalence and control in sleep-disordered breathing: the European sleep apnea cohort (ESADA) study. Chest. 2014;146(4):982–990.
  • Kent BD, Grote L, Bonsignore MR, et al. Sleep apnoea severity independently predicts glycaemic health in nondiabetic subjects: the ESADA study. Eur Respir J. 2014;44(1):130–139.
  • Meslier N, Gagnadoux F, Giraud P, et al. Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome. Eur Respir J. 2003;22(1):156–160.
  • Ronksley PE, Hemmelgarn BR, Heitman SJ, et al. Obstructive sleep apnoea is associated with diabetes in sleepy subjects. Thorax. 2009;64(10):834–839.
  • Botros N, Concato J, Mohsenin V, et al. Obstructive sleep apnea as a risk factor for type II diabetes. Am J Med. 2009;122(12):1122–1127.
  • Whitaker KM, Lutsky PL, Ogilvie RP, et al. Associations between polysomnography and actigraphy-based sleep indices and glycemic control among those with and without type 2 diabetes: the multi-ethnic study of atherosclerosis. Sleep. 2018;zsy172–zsy172.
  • Punjabi NM, Sorkin JD, Katzel LI, et al. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med. 2002;165(5):677–682.
  • Ip MSM, Lam B, Ng MMT, et al. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med. 2002;165(5):670–676.
  • Iftikhar IH, Hoyos CM, Phillips CL, et al. Meta-analyses of the association of sleep apnea with insulin resistance, and the effects of CPAP on HOMA-IR, adiponectin, and visceral adipose fat. J Clin Sleep Med. 2015;11(4):475–485.
  • Drager LF, Li J, Reinke C, et al. Intermittent hypoxia exacerbates metabolic effects of diet-induced obesity. Obesity (Silver Spring). 2011;19(11):2167–2174.
  • Gaines J, Vgontzas AN, Fernandez-Mendoza J, et al. Obstructive sleep apnea and the metabolic syndrome: the road to clinically-meaningful phenotyping, improved prognosis, and personalized treatment. Sleep Med Rev. 2018;42:211–219.
  • Jullian-Desayes I, Joyeux-Faure M, Tamisier R, et al. Impact of obstructive sleep apnea treatment by continuous positive airway pressure on cardiometabolic biomarkers: a systematic review from sham CPAP randomized controlled trials. Sleep Med Rev. 2015;21:23–38.
  • Bonsignore MR, Borel A-L, Machan E, et al. Sleep apnoea and metabolic dysfunction. Eur Respir Rev. 2013;22(129):353–364.
  • Acosta-Castro P, Page C. REM-associated sleep apnoea: prevalence and clinical significance in the HypnoLaus cohort. Eur Respir J. 2018;52(2).
  • Nobili V, Cutrera R, Liccardo D, et al. Obstructive sleep apnea syndrome affects liver histology and inflammatory cell activation in pediatric nonalcoholic fatty liver disease, regardless of obesity/insulin resistance. Am J Respir Crit Care Med. 2014;189(1):66–76.
  • Sundaram SS, Halbower A, Pan Z, et al. Nocturnal hypoxia-induced oxidative stress promotes progression of pediatric non-alcoholic fatty liver disease. J Hepatol. 2016;65(3):560–569.
  • Sookoian S, Pirola CJ. Obstructive sleep apnea is associated with fatty liver and abnormal liver enzymes: a meta-analysis. Obes Surg. 2013;23(11):1815–1825.
  • Aron-Wisnewsky J, Clement K, Pépin J-L. Nonalcoholic fatty liver disease and obstructive sleep apnea. Metabolism. 2016;65(8):1124–1135.
  • Aron-Wisnewsky J, Minville C, Tordjman J, et al. Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese. J Hepatol. 2012;56(1):225–233.
  • Labarca G, Reyes T, Jorquera J, et al. CPAP in patients with obstructive sleep apnea and type 2 diabetes mellitus: systematic review and meta-analysis. Clin Respir J. 2018;12(8):2361–2368.
  • Ioachimescu OC, Anthony J, Constantin T, et al. VAMONOS (Veterans affairs’ metabolism, obstructed and non-obstructed sleep) study: effects of CPAP therapy on glucose metabolism in patients with obstructive sleep apnea. J Clin Sleep Med. 2017;13(3):455–466.
  • Mokhlesi B, Grimaldi D, Beccuti G, et al. Effect of one week of CPAP treatment of obstructive sleep apnoea on 24-hour profiles of glucose, insulin and counter-regulatory hormones in type 2 diabetes. Diabetes Obesity Metab. 2017;19(3):452–456.
  • Martínez-Cerón E, Barquiel B, Bezos A-M, et al. Effect of continuous positive airway pressure on glycemic control in patients with obstructive sleep apnea and type 2 diabetes. A randomized clinical trial. Am J Respir Crit Care Med. 2016;194(4):476–485.
  • Baslas V, Chand P, Jurel SK, et al. A pilot study to determine the effect of three months of oral appliance therapy using a mandibular advancement device on hba1c in subjects with type 2 diabetes mellitus and obstructive sleep Apnea. J Prosthodontics. 2018 Oct 8. [Epub ahead of print].
  • Noel P, Nedelcu M, Eddbali I, et al. What are the long-term results 8 years after sleeve gastrectomy? Surg Obesity Related Dis. 2017;13(7):1110–1115.
  • Kim D, Ahmed A, Kushida C. Continuous positive airway pressure therapy on nonalcoholic fatty liver disease in patients with obstructive sleep apnea. J Clin Sleep Med. 2018;14(8):1315–1322.
  • Sundaram SS, Halbower AC, Klawitter J, et al. Treating obstructive sleep apnea and chronic intermittent hypoxia improves the severity of nonalcoholic fatty liver disease in children. J Pediatr. 2018;198:67–75.e1.
  • Gupta MA, Simpson FC. Obstructive sleep apnea and psychiatric disorders: a systematic review. J Clin Sleep Med. 2015;11(2):165–175.
  • Bassetti CL, Ferini-Strambi L, Brown S, et al. Neurology and psychiatry: waking up to opportunities of sleep.: state of the art and clinical/research priorities for the next decade. Eur J Neurol. 2015;22(10):1337–1354.
  • Stubbs B, Vancampfort D, Veronese N, et al. The prevalence and predictors of obstructive sleep apnea in major depressive disorder, bipolar disorder and schizophrenia: A systematic review and meta-analysis. J Affect Disord. 2016;197:259–267.
  • Haba-Rubio J, Marti-Soler H, Tobback N, et al. Sleep characteristics and cognitive impairment in the general population: the HypnoLaus study. Neurology. 2017;88(5):463–469.
  • Sforza E, Saint Martin M, Barthélémy JC, et al. Mood disorders in healthy elderly with obstructive sleep apnea: a gender effect. Sleep Med. 2016;19:57–62.
  • Hermann DM, Bassetti CL. Role of sleep-disordered breathing and sleep-wake disturbances for stroke and stroke recovery. Neurology. 2016;87(13):1407–1416.
  • Chen Y-H, Keller JK, Kang J-H, et al. Obstructive sleep apnea and the subsequent risk of depressive disorder: a population-based follow-up study. J Clin Sleep Med. 2013;9(5):417–423.
  • Buratti L, Luzzi S, Petrelli C, et al. Obstructive sleep apnea syndrome: an emerging risk factor for dementia. CNS Neurol Disord Drug Targets. 2016;15(6):678–682.
  • Ding X, Kryscio RJ, Turner J, et al. Self-reported sleep apnea and Dementia risk: findings from the prevention of alzheimer’s disease with vitamin E and selenium trial. J Am Geriatr Soc. 2016;64(12):2472–2478.
  • Lutsey PL, Norby FL, Gottesman RF, et al. Sleep Apnea, sleep duration and brain MRI markers of cerebral vascular disease and alzheimer’s disease: the atherosclerosis risk in communities study (ARIC). PLoS One. 2016;11(7):e0158758.
  • Redine S, Yenokyan G, Gottlieb DJ, et al. Obstructive sleep apnea hypopnea and incident stroke. Am J Respir Crit Care Med. 2010;182(2):269–277.
  • Stone KL, Blackwell TL, Ancoli-Israel S, et al. Sleep disordered breathing and risk of stroke in older community-dwelling men. Sleep. 2016;39(3):531–540.
  • Poli M, Philip P, Taillard J, et al. Atrial fibrillation is a major cause of stroke in apneic patients: a prospective study. Sleep Med. 2017;30:251–254.
  • Dong R, Dong Z, Liu H, et al. Prevalence, risk factors, outcomes, and treatment of obstructive sleep apnea in patients with cerebrovascular disease: a systematic review. J Stroke Cerebrovascular Dis. 2018;27(6):1471–1480.
  • Canessa N, Castronovo V, Cappa SF, et al. Obstructive sleep apnea: brain structural changes and neurocognitive function before and after treatment. Am J Respir Crit Care Med. 2011;183(10):1419–1426.
  • Castronovo V, Scifo P, Castellano A, et al. White matter integrity in obstructive sleep apnea before and after treatment. Sleep. 2014;37(9):1465–1475.
  • Rosenzweig I, Glasser M, Polsek D, et al. Sleep apnoea and the brain: a complex relationship. Lancet Respir Med. 2015;3(5):404–414.
  • Kerner NA, Roose SP. Obstructive sleep apnea is linked to depression and cognitive impairment: evidence and potential mechanisms. Am J Geriatr Psychiatry. 2016;24(6):496–508.
  • Osorio RS, Gumb T, Pirraglia E, et al. Sleep-disordered breathing advances cognitive decline in the elderly. Neurology. 2015;84(19):1964–1971.
  • Snyder, B., Shell, B., Cunningham, J.T., et al. Chronic intermittent hypoxia induces oxidative stress and inflammation in brain regions associated with early-stage neurodegeneration. Physiol Rep. 2017;5(9).
  • Daulatzai MA. Evidence of neurodegeneration in obstructive sleep apnea: relationship between obstructive sleep apnea and cognitive dysfunction in the elderly. J Neurosci Res. 2015;93(12):1778–1794.
  • Yaffe K, Falvey CM, Hoang T. Connections between sleep and cognition in older adults. Lancet Neurol. 2014;13(10):1017–1028.
  • Kim Y, Koo YS, Lee HY, et al. Can continuous positive airway pressure reduce the risk of stroke in obstructive sleep apnea patients? A systematic review and meta-analysis. PLoS ONE. 2016;11(1):e0146317.
  • Iranzo A, Santamaría J, Berenguer J, et al. Prevalence and clinical importance of sleep apnea in the first night after cerebral infarction. Neurology. 2002;58(6):911–916.
  • Gupta A, Shukla G, Afsar M, et al. Role of positive airway pressure therapy for obstructive sleep apnea in patients with stroke: a randomized controlled trial. J Clin Sleep Med. 2018;14(4):511–521.
  • Povitz M, Bolo CE, Heitman SJ, et al. Effect of treatment of obstructive sleep apnea on depressive symptoms: systematic review and meta-analysis. PLoS Med. 2014;11(11):e1001762.
  • McNicholas WT. COPD-OSA overlap syndrome: evolving evidence regarding epidemiology, clinical consequences, and management. Chest. 2017;152(6):1318–1326.
  • Krachman SL, Tiwari R, Vega ME, et al. Effect of emphysema severity on the Apnea–hypopnea index in smokers with obstructive sleep Apnea. Ann Am Thorac Soc. 2016;13(7):1129–1135.
  • Zhao YY, Blackwell T, Ensrud KE, et al. Sleep apnea and obstructive airway disease in older men: outcomes of sleep disorders in older men study. Sleep. 2016;39(7):1343–1351.
  • Greenberg-Dotan S, Reuveni H, Tal A, et al. Increased prevalence of obstructive lung disease in patients with obstructive sleep apnea. Sleep Breathing. 2014;18(1):69–75.
  • Sanders MH, Newman AB, Haggerty CL, et al. Sleep and sleep-disordered breathing in adults with predominantly mild obstructive airway disease. Am J Respir Crit Care Med. 2003;167(1):7–14.
  • McNicholas WT. Chronic obstructive pulmonary disease and obstructive sleep apnea: overlaps in pathophysiology, systemic inflammation, and cardiovascular disease. Am J Respir Crit Care Med. 2009;180(8):692–700.
  • Chaouat A, Naeije R, Weitzenblum E. Pulmonary hypertension in COPD. Eur Resp J. 2008;32(5):1371–1385.
  • Kim MY, Jo E-J, Kang S-Y, et al. Obstructive sleep apnea is associated with reduced quality of life in adult patients with asthma. Ann Allergy Asthma Immunol. 2013;110(4):253–7, 257 e1.
  • Luyster FS, Teodorescu M, Bleecker E, et al. Sleep quality and asthma control and quality of life in non-severe and severe asthma. Sleep Breath. 2012;16(4):1129–1137.
  • Kong DL, Qin Z, Shen H, et al. Association of obstructive sleep apnea with asthma: A meta-analysis. Sci Rep. 2017;7(1):4088.
  • Teodorescu M, Consens FB, Bria WF, et al. Correlates of daytime sleepiness in patients with asthma. Sleep Med. 2006;7(8):607–613.
  • Teodorescu M, Polomis DA, Hall SV, et al. Association of obstructive sleep apnea risk with asthma control in adults. Chest. 2010;138(3):543–550.
  • Broytman O, Braun RK, Morgan BJ, et al. Effects of chronic intermittent hypoxia on allergen-induced airway inflammation in rats. Am J Respir Cell Mol Biol. 2015;52(2):162–170.
  • Mermigkis C, Bouloukaki I, Schiza SE. Sleep as a new target for improving outcomes in idiopathic pulmonary fibrosis. Chest. 2017;152(6):1327–1338.
  • Bosi M, Milioli G, Fanfulla F, et al. OSA and prolonged oxygen desaturation during sleep are strong predictors of poor outcome in IPF. Lung. 2017;195(5):643–651.
  • Lee RN, Kelly E, Nolan G, et al. Disordered breathing during sleep and exercise in idiopathic pulmonary fibrosis and the role of biomarkers. Qjm. 2015;108(4):315–323.
  • Braun, R.K., Broytman, O., Braun, F.M., et al. Chronic intermittent hypoxia worsens bleomycin-induced lung fibrosis in rats. Respir Physiol Neurobiol. 2018;256:97-108.
  • van Hees HWH, Dekhuijzen PNR, Heunks LMA. Levosimendan enhances force generation of diaphragm muscle from patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009;179:41–47.
  • Gille T, Didier M, Boubaya M, et al. Obstructive sleep apnoea and related comorbidities in incident idiopathic pulmonary fibrosis. Eur Respir J. 2017;49(6):1601934.
  • Struik, F.M., Lacasse, Y., Goldstein, R., et al. Nocturnal non-invasive positive pressure ventilation for stable chronic obstructive pulmonary disease. Cochrane Database Rev. 2013;13:CD002878.
  • Köhnlein T, Windisch W, Köhler D, et al. Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial. Lancet Respir Med. 2014;2(9):698–705.
  • Murphy PB, Rehal S, Arbane G, et al. Effect of home noninvasive ventilation with oxygen therapy vs oxygen therapy alone on hospital readmission or death after an acute copd exacerbation: A randomized clinical trial. JAMA. 2017;317(21):2177–2186.
  • Marin JM, Soriano JB, Carrizo SJ, et al. Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep Apnea. Am J Respir Crit Care Med. 2010;182(3):325–331.
  • Machado, M.-C.L., Vollmer, W.M., Togeiro, S.M., et al. CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD. Eur Respir J. 2010;35(1):132–137.
  • Lyons OD, Inami T, Perger E, et al. The effect of fluid overload on sleep apnoea severity in haemodialysis patients. Eur Respir J. 2017;49(4):1601789.
  • Adams, R.J., Appleton, S.L., Vakulin, A., et al. Chronic kidney disease and sleep apnea association of kidney disease with obstructive sleep apnea in a population study of men. Sleep. 2017;40(1):zsw015–zsw015.
  • Marrone O, Battaglia S, Steiropoulos P, et al. Chronic kidney disease in European patients with obstructive sleep apnea: the ESADA cohort study. J Sleep Res. 2016;25(6):739–745.
  • Jaussent, I., Cristol, J.P., Stengel, B., et al. Impact of sleep disturbances on kidney function decline in the elderly. Eur Respir J. 2016;47(3):860–868.
  • Nicholl, D.D.M., Hanly, P.J., Poulin, M.J., et al. Evaluation of continuous positive airway pressure therapy on renin–angiotensin system activity in obstructive sleep apnea. Am J Respir Crit Care Med. 2014;190(5):572–580.
  • Marrone O, Cibella F, Pépin JL, et al. Fixed But Not Autoadjusting Positive Airway Pressure Attenuates the Time-dependent Decline in Glomerular Filtration Rate in Patients With OSA. ESADA Network. Chest. 2018 Aug;154(2):326–334.
  • Mahajan, S., Gupta, K., Sinha, S., et al. Effect of kidney transplantation on sleep-disordered breathing in patients with end stage renal disease: a polysomnographic study. Sleep Med. 2018;45:140–145.
  • Zhang XB, Peng L-H, Lyu Z, et al. Obstructive sleep apnoea and the incidence and mortality of cancer: a meta-analysis. Eur J Cancer Care (Engl). 2017;26(2).
  • Martínez-García MÁ, Campos-Rodríguez F, Almendros I, et al. Relationship between sleep apnea and cancer. Archivos de Bronconeumología. 2015;51(9):456–461.
  • Campos-Rodriguez F, Martinez-Garcia MA, Martinez M, et al. Association between obstructive sleep apnea and cancer incidence in a large multicenter Spanish cohort. Am J Respir Crit Care Med. 2013;187(1):99–105.
  • Zhang X-B, Peng L-H, Lyu Z, et al. Obstructive sleep apnoea and the incidence and mortality of cancer: a meta-analysis. Eur J Cancer Care (Engl). 2017;26(2):e12427.
  • Gozal D, Farré R, Nieto FJ. Obstructive sleep apnea and cancer: epidemiologic links and theoretical biological constructs. Sleep Med Rev. 2016;27:43–55.
  • Almendros I, Montserrat JM, Torres M, et al. Obesity and intermittent hypoxia increase tumor growth in a mouse model of sleep apnea. Sleep Med. 2012;13(10):1254–1260.
  • Gozal D, Farré R, Nieto FJ. Putative links between sleep apnea and cancer: from hypotheses to evolving evidence. Chest. 2015;148(5):1140–1147.
  • Almendros I, Montserrat JM, Ramírez J, et al. Intermittent hypoxia enhances cancer progression in a mouse model of sleep apnoea. Eur Respir J. 2012;39(1):215–217.
  • Gupta MA, Simpson FC, Gupta AK. Psoriasis and sleep disorders: A systematic review. Sleep Med Rev. 2016;29:63–75.
  • Gupta MA, Simpson FC, Vujcic B, et al. Obstructive sleep apnea and dermatologic disorders. Clin Dermatol. 2017;35(3):319–327.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.